Login / Signup

Paclitaxel plus cisplatin and 5-fluorouracil induction chemotherapy for locally advanced borderline-resectable esophageal squamous cell carcinoma: a phase II clinical trial.

Zhiqiang WangMingtao HuYihuai HuQiaoqiao LiJiadi WuWilliam Pat FongChao RenDeshen WangQiong TanHong YangYu-Hong Li
Published in: Esophagus : official journal of the Japan Esophageal Society (2021)
ClinicalTrials.gov identifier: NCT02976909.
Keyphrases
  • phase ii
  • clinical trial
  • locally advanced
  • open label
  • rectal cancer
  • chemotherapy induced
  • squamous cell carcinoma
  • radiation therapy
  • phase iii
  • double blind
  • placebo controlled
  • liver metastases
  • study protocol